U.S., April 9 -- An application to own the trademark for 'RDRUG' has been filed on Oct. 10, 2024.
Owner(s):
Rgenta Therapeutics, Inc.; 300 TradeCenter Drive, Suite 6600, Massachusetts
Goods and/or Services:
For: Small molecule pharmaceutical preparations for use in cell and gene therapy for treating respiratory and infectious diseases and metabolic disorders, and diseases and disorders of the neurological, oncology, cardiovascular, immune, endocrine , gastrointestinal, ophthalmic, dermatologic and hematologic systems
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-04-08&serialNumber=98794435
Disclaimer: Curated by HT Syndication....